|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
SATRALIZUMAB |
L04AC19 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
RIPRETINIB |
L01EX19 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
ARTESUNATE |
P01BE03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
ABROCITINIB |
D11AH08 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
VOXELOTOR |
B06AX03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
FINERENONE |
C03DA05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
DE
|
I
|
14-11-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
